Reactivation of replication of hepatitis B and C viruses after immunosuppressive therapy: an unresolved issue.
about
New perspectives in occult hepatitis C virus infectionLamivudine for preventing reactivation of hepatitis B infection in patients planned to undergo immunosuppressive therapyKASL clinical practice guidelines: management of hepatitis CHepatitis B and Hepatitis C Reactivation in the Biologic EraHepatitis B virus reactivation with rituximab-containing regimenCancer and liver cirrhosis: implications on prognosis and managementCommon Infections in Patients Prescribed Systemic Glucocorticoids in Primary Care: A Population-Based Cohort StudyClinical and prognostic analysis of hepatitis B virus infection in diffuse large B-cell lymphoma.Prevention of hepatitis B virus reactivation under rituximab therapy.Hidden hazards of HCV transmission.Safety of antitumour necrosis factor (anti-TNF) therapy in patients with chronic viral infections: hepatitis C, hepatitis B, and HIV infection.Chronic hepatitis virus infection in patients with multiple myeloma: clinical characteristics and outcomes.Hepatitis B virus (HBV) reactivation with immunosuppressive therapy in rheumatic diseases: assessment and preventive strategiesReactivation of hepatitis B virus with rituximab.A fatal case of hepatitis B virus (HBV) reactivation during long-term, very-low-dose steroid treatment in an inactive HBV carrier.Hepatitis B virus reactivation in patients receiving chemotherapy for cancer treatment: role of Lamivudine prophylaxis.Screening, prevention and treatment of viral hepatitis B reactivation in patients with haematological malignancies.Long-term outcome after prophylactic lamivudine treatment on hepatitis B virus reactivation in non-Hodgkin's lymphoma.Reactivation of hepatitis B virus and hepatitis C virus in patients with cancer.Reactivation of hepatitis B virus in patients receiving chemotherapy.Reactivation of hepatitis viruses following immunomodulating systemic chemotherapy.Challenges in managing hepatitis C virus infection in cancer patients.Reactivation of Hepatitis C Virus and Its Clinical Outcomes in Patients Treated with Systemic Chemotherapy or Immunosuppressive Therapy.Hepatitis B reactivation during or after direct acting antiviral therapy - implication for susceptible individuals.The serological markers of acute infection with hepatitis A, B, C, D, E and G viruses revisited.Hepatitis C virus reactivation in patients receiving cancer treatment: A prospective observational study.Concomitant use of direct-acting antivirals and chemotherapy in hepatitis C virus-infected patients with cancer.Assessment of 4 Cases of Kidney Transplantation from Hepatitis C Virus Antibody-Positive and RNA-Negative Donors to Antibody-Negative Recipients.Impact of anti-inflammatory drug consumption in peritonsillar abscesses: a retrospective cohort studyHow I treat hepatitis C virus infection in patients with hematologic malignancies.Rituximab administration and reactivation of HBV.Management of HBV infection during immunosuppressive treatmentClinical analysis and prognostic significance of hepatitis B virus infections for diffuse large B-cell lymphoma with or without rituximab therapy.Treatment of acute hepatitis C in breast cancer patient: a case report.Prevalence and factors related to hepatitis B and C infection in inflammatory bowel disease patients in China: a retrospective study.Effect of immunosuppressive therapy on patients with inflammatory bowel diseases and hepatitis B or C virus infection.Hepatitis C virus infection prevalence and liver dysfunction in a cohort of B-cell non-Hodgkin's lymphoma patients treated with immunochemotherapy.Effect of immune modulation on TT virus (TTV) and TTV-like-mini-virus (TLMV) viremia.Lamivudine for the prevention of hepatitis B virus reactivation after high-dose chemotherapy and autologous hematopoietic stem cell transplantation for patients with advanced or relapsed non-Hodgkin's lymphoma single institution experience.Kinetics of peripheral hepatitis B virus-specific CD8+ T cells in patients with onset of viral reactivation.
P2860
Q22305491-104A2FD0-9620-4EF6-A409-36654DC82FAFQ24240881-4C64ECAC-FC4D-49BB-8FF9-74BB128227D4Q26752471-D60B3765-0BD2-4E3E-B8F6-4C85346C2FF9Q26781993-C9EF0D37-F95D-4A65-92F4-2A62BAD644AFQ26830484-5346388B-1C87-4A91-9619-2C207C129B17Q28068579-365587A5-3AD4-4951-AD2C-DCC7862B6F36Q28602277-DA2C29C2-6BAF-4E21-8C83-DCC25A070CA4Q33330483-EAB4ADAD-ED5A-4C88-B909-C06663F46807Q33390799-BACA36E6-2351-44C6-821B-D4492407C213Q34114816-19CCBB46-5624-40FB-A7F5-AC1A863B26A6Q35579382-D49533E4-7B86-432A-8020-E9A540BC1C92Q35580212-F1A56F55-32BB-4C50-8F24-09B63286355BQ35637506-786D9D46-68AB-4746-8D8C-B32A0A70A565Q36150595-ED669CA0-210F-4A0E-A802-1284A8D53DB8Q36154001-50C72B78-9F18-4277-9A36-E82E702A7887Q36581066-D158ACF1-1771-4712-8506-4606F7C04BF7Q36752181-E31F95F2-8290-45F7-9347-51DB36271079Q37065113-6EF79E5A-22F6-4384-AD55-2B2CB21867C4Q37978202-3055FC45-5AAA-4F2C-9344-C1D6D026CE69Q38062818-3964557D-208B-44B2-8DBA-C7BD5DA2CC48Q38062943-0E33F489-B5CF-444F-BA4B-66AD928F676FQ38198615-8825D48B-39D6-4019-BA9F-05D1687AF2E8Q38657207-7A5A57DF-D592-400D-9A2A-15B1CC8F7A18Q38805093-9DDCF7C4-79E7-4245-947A-EC3318403754Q40051750-F3AC7C61-611C-4016-BF55-97ACFABF58F2Q40144152-55FA5A64-4BFC-485A-8E7D-0758ACD3C447Q40487793-0F5303DB-E958-408B-BCE3-BB537866BDE8Q40504412-E66C5340-EBD5-4CA2-B6AC-38F99537C3C7Q40568948-DE61B4AF-B6D1-4688-BE4F-7EDE3F96FA0AQ40604797-A4C014D6-6C30-473B-A685-C2FD5C189794Q41215683-4EEAEEAA-0028-4273-98D1-1CFCC51EF883Q41859437-C79FFC0F-49DB-4860-BCFC-6D5C564027EBQ42121505-260A8663-D934-4955-88F2-A9BD0C09EBF2Q42232094-F02E7EDB-D3F5-466A-A45C-E2CDE97B1F7DQ42267006-6673C7A4-4452-4479-867B-89931E62D5A3Q42988930-AD9F27B6-B0E5-4E04-A668-8F0F8DC8EDBAQ43040370-80C3A50C-E1A9-442B-A6C0-9FDF653DA127Q43049327-ABDD041C-D873-46FF-835B-4BB91FE9F41CQ43275329-8F149337-C149-4570-9E12-124D767F9BF7Q44218960-E9F86D42-B870-4DD4-A2D7-6039759D0FA6
P2860
Reactivation of replication of hepatitis B and C viruses after immunosuppressive therapy: an unresolved issue.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Reactivation of replication of ...... therapy: an unresolved issue.
@ast
Reactivation of replication of ...... therapy: an unresolved issue.
@en
Reactivation of replication of ...... therapy: an unresolved issue.
@nl
type
label
Reactivation of replication of ...... therapy: an unresolved issue.
@ast
Reactivation of replication of ...... therapy: an unresolved issue.
@en
Reactivation of replication of ...... therapy: an unresolved issue.
@nl
prefLabel
Reactivation of replication of ...... therapy: an unresolved issue.
@ast
Reactivation of replication of ...... therapy: an unresolved issue.
@en
Reactivation of replication of ...... therapy: an unresolved issue.
@nl
P1433
P1476
Reactivation of replication of ...... therapy: an unresolved issue.
@en
P2093
Maria Serena Longhi
P304
P356
10.1016/S1470-2045(02)00773-8
P577
2002-06-01T00:00:00Z